Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01923584 · ClinicalTrials.gov registry record · Phase 2
A Phase 2A Trial of EPI-743 for Patients With Parkinson's Disease
A Phase 2 study, sponsored by University of South Florida.
- Completed
- Registry status
- Phase 2
- Development phase
- 15
- Enrollment target
NCT01923584: Completed Phase 2 study, sponsored by University of South Florida.
NCT01923584 is a Phase 2 study that has completed, run by University of South Florida. The registered enrollment target is 15 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01923584, a Phase 2 study, has completed, sponsored by University of South Florida.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 15 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effects of EPI-743 in patients with Parkinson's disease.
Primary Outcome
electroretinogram and color vision
Interventions
- DRUG EPI-743 400mg
- DRUG EPI-743 200mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2013-09 |
| Est. Completion | 2016-06 |
| Phase | Phase 2 |
What the finished NCT01923584 record still lists
NCT01923584 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (89% lower).
The record links to 0 conditions, and to 2 interventions - of which EPI-743 400mg is the first listed.
NCT01923584 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01923584 about?
NCT01923584 is a clinical study titled "A Phase 2A Trial of EPI-743 for Patients With Parkinson's Disease". The purpose of this study is to evaluate the effects of EPI-743 in patients with Parkinson's disease.
What is the current status of trial NCT01923584?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 15 participants. The study started on 2013-09. Estimated completion is 2016-06.
What interventions are being tested in trial NCT01923584?
The interventions under investigation include: EPI-743 400mg (DRUG), EPI-743 200mg (DRUG).
Who is sponsoring clinical trial NCT01923584?
This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01923584's enrollment target sits among peer trials
15 1919th of 2000 higher than 60 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia